Intestinal stem cell differentiation

Intestinal stem cell differentiation is a complex biological process rather than a single molecular target. It involves the maturation of multipotent Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5+) stem cells located in the crypts of Lieberkühn into specialized cell types, including absorptive enterocytes and secretory cells like goblet, Paneth, and enteroendocrine cells (Clevers, 2013). This transition is governed by a precise gradient of signaling activities, most notably the Wnt and Notch pathways which maintain stemness and promote lineage specification, respectively (Barker et al., 2007). In diseases such as colorectal cancer, the differentiation program is often highjacked or stalled, leading to the expansion of undifferentiated cancer stem cells (Drost & Clevers, 2018). While there is no single drug that 'binds' to this process, therapeutic interventions target specific components of the underlying pathways—such as porcupine inhibitors (LGK974) for Wnt or gamma-secretase inhibitors (DAPT) for Notch—to force differentiation or inhibit progenitor proliferation in oncogenic contexts (Takebe et al., 2015).

Other names

ISC differentiationGut epithelial maturationIntestinal lineage specification

Modulation of core signaling pathways such as Wnt, Notch, BMP, and Hedgehog to influence the transition from multipotent stem cells to specialized epithelial lineages.